WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Transcutaneous bilirubin concentration measuring apparatus and a measurement data checking plate for use with the same    
United States Patent6847835   
Link to this pagehttp://www.wikipatents.com/6847835.html
Inventor(s)Yamanishi; Akio (Hyogo-Ken, JP)
AbstractLuminous fluxes from a xenon tube are introduced from one end of an optical fiber to an other end thereof and emerge therefrom. These luminous fluxes are incident of a skin of a person to be measured, and those diffused in the skin are incident on one end of an optical fiber through a first incident port and on one end of an optical fiber through a second incident port. The luminous fluxes from the one end are split by a dichroic mirror. The luminous fluxes reflected by the dichroic mirror are received by a photoelectric conversion element via a blue filter, and those having transmitted through the dichroic mirror are received by a photoelectric conversion element via a green filter. A concentration of bilirubin pigmented in fat of subcutaneous tissues can be accurately measured without being influenced by a difference in the thicknesses of epidermis and derma.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 6847835
Transcutaneous bilirubin concentration measuring apparatus and a

         measurement data checking plate for use with the same - US Patent 6847835 Drawing
Transcutaneous bilirubin concentration measuring apparatus and a measurement data checking plate for use with the same
Inventor     Yamanishi; Akio (Hyogo-Ken, JP)
Owner/Assignee     Minolta Co., Ltd. (Osaka, JP)
Patent assignment
All assignments
Publication Date     January 25, 2005
Application Number     09/536,762
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     March 28, 2000
US Classification     600/315 600/310 600/322
Int'l Classification     A61B 005/00
Examiner     Winakur; Eric F.
Assistant Examiner     Kremer; Matthew
Attorney/Law Firm     McDermott Will & Emery LLP
Address
Parent Case    
Priority Data     Mar 31, 1999[JP]11-092632
USPTO Field of Search     600/309 600/310 600/315 600/316 600/322 600/326 600/336 600/309 600/310 356/39 356/40 356/41 356/42
Patent Tags     transcutaneous bilirubin concentration measuring a measurement data checking plate
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
6134458
Rosenthal
600/310
Oct,2000

[0 after 0 votes]
5983120
Groner
600/310
Nov,1999

[0 after 0 votes]
5879294
Anderson
600/310
Mar,1999

[0 after 0 votes]
5830132
Robinson
600/310
Nov,1998

[0 after 0 votes]
5825488
Kohl
356/342
Oct,1998

[0 after 0 votes]
5791345
Ishihara

Aug,1998

[0 after 0 votes]
5770454
Essenpreis

Jun,1998

[0 after 0 votes]
5513642
Ostrander
600/334
May,1996

[0 after 0 votes]
5353790
Jacques
600/315
Oct,1994

[0 after 0 votes]
5297554
Glynn

Mar,1994

[0 after 0 votes]
4267844
Yamanishi
600/315
May,1981

[0 after 0 votes]
4236826
Yamanishi
356/432
Dec,1980

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A bilirubin concentration measuring apparatus, comprising:

(a) a light emitter for emitting a light which includes a first luminous flux falling in a first wavelength range and a second luminous flux falling in a second wavelength range, their bilirubin absorption coefficients differing from each other;

(b) a light emerging port for projecting the light including the first and second luminous fluxes from the light emitter onto skin of a person for entering thereinto;

(c) a first light incident port for allowing the first and second luminous fluxes having been diffused in tissues of the person to pass therethrough;

(d) a second light incident port for allowing the first and second luminous fluxes having been diffused in tissues of the person to pass therethrough, the second light incident port being spaced away from the light emerging port a different distance than the first light incident port, so that optical path length of luminous fluxes which pass through the first light incident port and optical path length of luminous fluxes which pass through the second light incident port are different from each other;

(e) a first electric signal generator for generating a first electric signal corresponding to an intensity of the first luminous flux passed through the first light incident port, and a second electric signal corresponding to an intensity of the second luminous flux passed through the first light incident port;

(f) a second electric signal generator for generating a third electric signal corresponding to an intensity of the first luminous flux passed through the second light incident port, and a fourth electric signal corresponding to an intensity of the second luminous flux passed through the second light incident port; and

(g) a calculator for calculating a bilirubin concentration based on the first to fourth electric signals se that includes a processor that cancels the influence of skin by using the luminous fluxes of the different optical path length.

2. The apparatus according to claim 1, wherein:

the light emerging port has the form of a circle and is disposed in a middle of a light incident plane;

the first light incident port has the form of a ring and is disposed on an outside of the light emerging port; and

the second light incident port has the form of a ring and is disposed on an outside of the first light incident port.

3. The apparatus according to claim 1, wherein:

the light emitter includes a white light source operable to emit white light containing the first and second luminous fluxes;

the first signal generator includes:

a first light splitter for splitting the diffused luminous fluxes passed through the first light incident port into the first luminous flux and the second luminous flux;

a first photoelectric conversion device for generating the first electric signal corresponding to the intensity of the first luminous flux split by the first light splitter; and

a second photoelectric conversion device for generating the second electric signal corresponding to the intensity of the second luminous flux split by the first light splitter; and

the second signal generator includes:

a second light splitter for splitting the diffused luminous fluxes passed through the

second light incident port into the first luminous flux and the second luminous flux; a third photoelectric conversion device for generating the third electric signal corresponding to the intensity of the first luminous flux split by the second light splitter; and

a fourth photoelectric conversion device for generating the fourth electric signal corresponding to the intensity of the second luminous flux split by the second light splitter.

4. The apparatus according to claim 3, further comprising:

a first light guiding member for guiding the diffused luminous fluxes passed through the first light incident port to the first light splitter; and

a second light guiding member for guiding the diffused luminous fluxes passed through the second light incident port to the second light splitter.

5. The apparatus according to claim 1, further comprising:

an emission controller for controlling the emission of the light emitter, wherein

the light emitter includes:

a first light source operable to emit the first luminous flux; and

a second light source operable to emit the second luminous flux;

the emission controller controls the first and second light sources to emit the first and second luminous fluxes separately;

the first electric signal generator includes a first photoelectric conversion device operable to individually generate the first and second electric signals based on the first and second luminous fluxes separately passed through the first light incident port; and

the second electric signal generator includes a second photoelectric conversion device operable to individually generate the third and fourth electric signals based on the first and second luminous fluxes separately passed through the second light incident port.

6. The apparatus according to claim 5, further comprising:

a first light guiding member for guiding the diffused luminous fluxes passed through the first light incident port to the first photoelectric conversion device; and

a second light guiding member for guiding the diffused luminous fluxes passed through the second light incident port to the second photoelectric conversion device.

7. The apparatus according to claim 5, wherein the first light source includes a blue light emitting diode, and the second light source includes a green light emitting diode or a red light emitting diode.

8. The apparatus according to claim 1, wherein the first luminous flux is absorbable by bilirubin, and the second luminous flux is hardly absorbable by bilirubin.

9. The apparatus according to claim 1, further comprising a memory for storing first to fourth constants corresponding to the first to fourth electric signals, respectively, wherein the calculator executes:

calculation of first to fourth products by multiplying the first to fourth electric signals by the first to fourth constants;

calculation of a first logarithmic number of a quotient obtained by division of the second product by the first product;

calculation of a second logarithmic number of a quotient obtained by division of the fourth product by the third product; and

calculation of a bilirubin concentration based on a difference between the calculated two logarithmic numbers.

10. The apparatus according to claim 9, further comprising:

a constant calculator for calculating the first to fourth constants; and

a storage controller for controlling storage of the calculated first to fourth constants in the memory, wherein the constant calculator calculates the first to fourth constants to assure the following relationships:

1) a product of a first white electric signal and the first constant is equal to a product of a second white electric signal and the second constant; and

2) a product of a third white electric signal and the third constant is equal to a product of a fourth white electric signal and the fourth constant,

wherein the first to fourth white electric signals are first to second electric signals which are obtained under conditions where the first and second luminous fluxes are projected onto a white diffuser having no wavelength dependency, and the first and second luminous fluxes from the white diffuser are received after having passed through the first and second light incident ports.

11. The apparatus according to claim 1, further comprising:

a projection operable to come into contact with skin of a person, the projection having a light-blocked potion and a non-light-blocked portion, wherein

the light emerging port, and the first and second light incident ports are provided in the non-light-blocked portion of the projection.

12. A bilirubin concentration measuring apparatus, comprising:

(a) a light emitter for emitting a light which includes a first luminous flux falling in a first wavelength range and a second luminous flux falling in a second wavelength range, their bilirubin absorption coefficients differing from each other;

(b) a light emerging port for projecting the light including the first and second luminous fluxes from the light emitter onto skin of a person for entering thereinto;

(c) a first light incident port for allowing the first and second luminous fluxes having been diffused in tissues of the person to pass therethrough;

(d) a second light incident port for allowing the first and second luminous fluxes having been diffused in tissues of the person to pass therethrough, wherein the first light incident port and the second light incident port have forms of ring or circle having relative different radii so that the second light incident port being spaced away from the light emerging port a different distance than the first light incident port;

(e) a first electric signal generator for generating a first electric signal corresponding to an intensity of the first luminous flux passed through the first light incident port, and a second electric signal corresponding to an intensity of the second luminous flux passed through the first light incident port;

(f) a second electric signal generator for generating a third electric signal corresponding to an intensity of the first luminous flux passed through the second light incident port, and a fourth electric signal corresponding to an intensity of the second luminous flux passed through the second light incident port; and

(g) a calculator for calculating a bilirubin concentration based on the first to fourth electric signals.

13. The apparatus according to claim 12, wherein:

the light emitter includes a white light source operable to emit white light containing the first and second luminous fluxes;

the first signal generator includes:

a first light splitter for splitting the diffused luminous fluxes passed through the first light incident port into the first luminous flux and the second luminous flux;

a first photoelectric conversion device for generating the first electric signal corresponding to the intensity of the first luminous flux split by the first light splitter; and

a second photoelectric conversion device for generating the second electric signal corresponding to the intensity of the second luminous flux split by the first light splitter; and

the second signal generator includes:

a second light splitter for splitting the diffused luminous fluxes passed through the second light incident port into the first luminous flux and the second luminous flux;

a third photoelectric conversion device for generating the third electric signal corresponding to the intensity of the first luminous flux split by the second light splitter; and

a fourth photoelectric conversion device for generating the fourth electric signal corresponding to the intensity of the second luminous flux split by the second light splitter.

14. The apparatus according to claim 12, further comprising:

an emission controller for controlling the emission of the light emitter, wherein

the light emitter includes:

a first light source operable to emit the first luminous flux; and

a second light source operable to emit the second luminous flux;

the emission controller controls the first and second light sources to emit the first and second luminous fluxes separately;

the first electric signal generator includes a first photoelectric conversion device operable to individually generate the first and second electric signals based on the first and second luminous fluxes separately passed through the first light incident port; and the second electric signal generator includes a second photoelectric conversion device operable to individually generate the third and fourth electric signals based on the first and second luminous fluxes separately passed through the second light incident port.

15. The apparatus according to claim 12, wherein the first luminous flux is absorbable by bilirubin, and the second luminous flux is hardly absorbable by bilirubin.

16. The apparatus according to claim 12, further comprising a memory for storing first to fourth constants corresponding to the first to fourth electric signals, respectively, wherein the calculator executes:

calculation of first to fourth products by multiplying the first to fourth electric signals by the first to fourth constants;

calculation of a first logarithmic number of a quotient obtained by division of the second product by the first product;

calculation of a second logarithmic number of a quotient obtained by division of the fourth product by the third product; and

calculation of a bilirubin concentration based on a difference between the calculated two logarithmic numbers.

17. The apparatus according to claim 12, further comprising:

a projection operable to come into contact with skin of a person, the projection having a lighted-blocked potion and a non-light-blocked portion, wherein

the light emerging port, and the first and second light incident ports are provided in the non-light-blocked portion of the projection.

18. A bilirubin concentration measuring apparatus, comprising:

a light emitter for emitting a light which includes a first luminous flux falling in a first wavelength range and a second luminous flux falling in a second wavelength range, their bilirubin absorption coefficients differing from each other;

a light emerging port for projecting the first and second luminous fluxes onto skin of a person;

a first light incident port for allowing the first and second luminous fluxes having been diffused in the skin to pass therethrough;

a second light incident port for allowing the first and second luminous fluxes having been diffused in the skin to pass therethrough, the second light incident port being spaced away from the light emerging port a different distance than the first light incident port;

a first electric signal generator for generating a first electric signal corresponding to an intensity of the first luminous flux passed through the first light incident port, and a second electric signal corresponding to an intensity of the second luminous flux passed through the first light incident port;

a second electric signal generator for generating a third electric signal corresponding to an intensity of the first luminous flux passed through the second light incident port, and a fourth electric signal corresponding to an intensity of the second luminous flux passed through the second light incident port; and

a calculator for calculating a bilirubin concentration based on the first to fourth electric signals wherein:

the first light incident port has the form of a circle and is disposed in a middle of a light incident plane;

the light emerging port has the form of a ring and is disposed on an outside of the first light incident port; and

the second light incident port has the form of a ring and is disposed on an outside of the light emerging port.
 Description Submit all comments and votes
 


This application is based on patent application No. 11-92632 filed in Japan, the contents of which are hereby incorporated by references.

BACKGROUND OF THE INVENTION

This invention relates to a bilirubin concentration measuring apparatus for transcutaneously measuring a bilirubin concentration in blood from the outside of a skin and a measurement data checking plate used therewith.

Generally, icterus, particularly severe icterus of new-born babies may cause a death or, even if they can escape from a death, it may progress to nuclear icterus which causes aftereffects such as cerebral palsy. Thus, the detection of icterus in an early stage is very crucial. The degree of icterus should be precisely detected by measuring a bilirubin concentration in blood serum collected from new-born babies. However, it is difficult to collect blood from all new-born babies and to measure the bilirubin concentration or it may bet often unnecessary.

Accordingly, the icterus of a patient has been diagnosed using an icterus detector disclosed in, e.g., U.S. Pat. No. 4,267,844 without collection of blood sample. This icterus detector includes a light source for emitting a light to the skin of a human body and at least two light receiving elements for responding to light components of the reflected light in at least two wavelength ranges whose absorption coefficients by bilirubin pigmented in subcutaneous fat differ from each other. The degree or stage of icterus is measured based on the outputs of the respective light receiving elements. In this way, the degree of icterus is indirectly measured by measuring the concentration of bilirubin pigmented in subcutaneous fat instead of measuring a serum bilirubin concentration.

However, since the above icterus detector measures the degree of icterus based on the reflected light from the skin, measurement results are likely to be influenced by a difference in the thicknesses of epidermis and derma located above the subcutaneous tissues containing fat where bilirubin is pigmented (e.g., a difference in the skin maturity of the new-born baby), the skin color of a patient, i.e., a race difference. Therefore, it is difficult to constantly and accurately measure the degree of icterus.

SUMMARY OF THE INVENTION

It is an object of the present invention to provide a transcutaneous bilirubin concentration measuring apparatus and a measuring data checking plate which are free of the problems residing in the prior art.

According to an aspect of the invention, a transcutaneous bilirubin concentration measuring apparatus comprises: a light emitter for emitting a first luminous flux falling in a first wavelength range and a second luminous flux falling in a second wavelength range, their bilirubin absorption coefficients differing from each other; a light emerging port for projecting the first and second luminous fluxes onto skin of a person; a first light incident port for allowing the first and second luminous fluxes having been diffused in the skin to pass therethrough; a second light incident port for allowing the first and second luminous fluxes having been diffused in the skin to pass therethrough, the second light incident port being spaced away from the light emerging port a different distance than the first light incident port; a first electric signal generator for generating a first electric signal corresponding to an intensity of the first luminous flux passed through the first light incident port, and a second electric signal corresponding to an intensity of the second luminous flux passed through the first light incident port; a second electric signal generator for generating a third electric signal corresponding to an intensity of the first luminous flux passed through the second light incident port, and a fourth electric signal corresponding to an intensity of the second luminous flux passed through the second light incident port; and a calculator for calculating a bilirubin concentration based on the first to fourth electric signals.

According to another aspect of the invention, a transcutaneous bilirubin concentration measuring apparatus comprises: a light emitter for emitting a first luminous flux falling in a first wavelength range, a second luminous flux falling in a second wavelength range, and a third luminous flux falling in a third wavelength range, the first luminous flux being absorbable by bilirubin, the second and third being hardly absorbable by bilirubin; a light emerging port for projecting the first to third luminous fluxes onto skin of a person; a light incident port for allowing the first to third luminous fluxes having been diffused in the skin to pass therethrough; an electric signal generator for generating first to third electric signals corresponding to intensities of the first to third luminous fluxes passed through the light incident port, respectively; and a calculator for calculating a bilirubin concentration based on the first to third electric signals.

According to still another aspect of the invention, a measurement data checking plate is used with a transcutaneous bilirubin concentration measuring apparatus, and comprises: a first light diffusing layer disposed in a top part of the plate and having substantially the same absorption coefficient for both a first luminous flux falling in a first wavelength range and a second luminous flux falling in a second wavelength range which are used in the bilirubin concentration measuring apparatus; and a second light diffusing layer disposed below the first light diffusing layer and having a higher absorption coefficient of the first luminous flux than of the second luminous flux.

These and other objects, features and advantages of the present invention will become more apparent upon a reading of the following detailed description and accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A is an entire perspective view showing an external configuration of a transcutaneous bilirubin concentration measuring apparatus according to a first embodiment of the invention;

FIG. 1B is an enlarged view of an projection portion of the measuring apparatus shown in FIG. 1A;

FIG. 1C is a front view of the projection portion;

FIG. 2 is a perspective diagram showing an optical system accommodated in a casing of the measuring apparatus shown in FIG. 1A;

FIG. 3 is a block diagram showing an electric construction of the measuring apparatus shown in FIG. 1A;

FIG. 4 is a sectional view of a new-born baby's skin diagrammatically showing optical paths when a light is incident on the skin;

FIG. 5 is a sectional view of new-born babies' skins diagrammatically showing optical paths when a light is incident on the skins;

FIG. 6 is a perspective diagram showing a modification of the optical system;

FIG. 7 is a block diagram showing an electric construction of a transcutaneous bilirubin concentration measuring apparatus having the optical system shown in FIG. 6;

FIG. 8 is a flowchart showing a measuring operation of the measuring apparatus shown in FIG. 6;

FIG. 9A is a perspective view of a modification of the projection portion;

FIG. 9B is a front view of the modified projection portion;

FIG. 10 is a perspective diagram showing an optical system accommodated in a casing having the projection portion shown in FIGS. 9A and 9B;

FIG. 11A is an entire perspective view showing a transcutaneous bilirubin concentration measuring apparatus according to a second embodiment of the invention;

FIG. 11B is an enlarged partial perspective view showing a projection portion of the measuring apparatus shown in FIG. 11A;

FIG. 12 is a perspective diagram showing an optical system of the measuring apparatus shown in FIG. 11A;

FIG. 13 is a block diagram showing an electric construction of the measuring apparatus shown in FIG. 11A;

FIG. 14 is a modification of the optical system according to the second embodiment;

FIG. 15 is a block diagram showing an electric construction of a transcutaneous bilirubin concentration measuring apparatus having the optical system shown in FIG. 14;

FIGS. 16A and 16B are sectional views showing modifications of the end face of the projection portion, respectively;

FIGS. 17A to 17C show a measurement data checking plate according to another embodiment of the invention, wherein FIG. 17A is a perspective view showing an external configuration of the checking plate, FIG. 17B is a sectional view showing an internal construction of a high concentration testing section, and FIG. 17C a sectional view showing an internal construction of a low concentration testing section; and

FIG. 18 is a sectional view showing a modification of the high concentration testing section of the checking plate shown in FIGS. 17A to 17C.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION

A construction of a transcutaneous bilirubin concentration measuring apparatus according to a first embodiment of the invention will be described with reference to FIGS. 1A to 1C. As shown in FIG. 1A, this measuring apparatus 10 has a casing 11 of such a size holdable in hand. In this casing 11 are arranged an optical system and electric elements to be described later. Further, a display 12 for displaying a measurement result, i.e., a concentration of bilirubin pigmented in subcutaneous fat is provided at the rear end of the upper surface of the casing 11.

A cylindrical projection 13 is projectably and retractably (as indicated by an arrow AR) mountable on the leading end of the casing 11. This projection 13 is biased in such a direction as to project from the casing 11 (arrow direction AR) by a biasing means (not shown) such as a spring member. When a person who conduct a measurement presses the projection 13 against a part, such as a forehead, of a person to be measured, it is pushed into the casing 11 against a biasing force of the biasing means, thereby driving a xenon tube 21 (see FIG. 2) described later.

In the middle of the end face of the projection 13 is provided, as shown in FIG. 1B, a round emerging port 14 through which luminous fluxes from the xenon tube 21 emerge out. An annular first incident port 15 is provided outside the emerging port 14, an annular second incident port 16 is provided outside the first incident port 15, and an annular light blocking portion 17 is provided at the outermost. As shown in FIG. 1C, the emerging port 14 and the first incident port 15, and the first and second incident ports 15 and 16 are partitioned by spacers 18, 19 painted in black, respectively. The light blocking portion 17 is applied with a matte finish and painted in black. Consequently, no external light is incident on the respective incident ports 15, 16.

When the projection 13 is pushed in to drive the xenon tube 21, white light from the xenon tube 21 emerges out through the emerging port 14 of the projection 13 shown in FIG. 1C and is incident on the skin of the person to be measured. Luminous fluxes diffused in the skin as described later are incident on the optical system provided in the casing 11 via the first and second incident ports 15, 16. Further, a power switch 11a and a reset switch 45 (see FIG. 3) are provided at a rear end of one side surface of the casing 11 in FIG. 1A and on a back surface thereof, respectively.

FIG. 2 shows an optical system 20 accommodated in the casing 11. The optical system 20 has the xenon tube 21 (light emitting means) as a light source, and a light (white light) having a plurality of wavelengths is produced when the xenon tube 21 is driven.

One end 23 of an optical fiber 22 which acts as a guiding means is opposed to the xenon tube 21. The light from the xenon tube 21 is introduced to an other end 24 of the optical fiber 22, and emerges out through the emerging port 14 of the projection 13 (see FIG. 1) therefrom. The emergent luminous fluxes are incident on the skin of the person to be measured, and those diffused in the skin as described later are incident on one end 261 of an optical fiber 251 via the first incident port 15 and on one end 262 of an optical fiber 252 via the second incident port 16 from the outer surface of the skin. In other words, the emerging port 14 coincides with the other end 24 of the optical fiber 22, the first incident port 15 coincides with the other end 261 of the optical fiber 251 and the second incident port 16 coincides with the one end 262 of the optical fiber 252.

The diffused luminous fluxes incident on the one end 261 of the optical fiber 251 are introduced to the other end 271 and emerged therefrom, whereas those incident on the one end 262 of the optical fiber 252 are introduced to the other end 272 and emerge therefrom.

The luminous fluxes emerged from the other ends 271 (272) are incident on a dichroic mirror 281 (282) for reflecting luminous fluxes in a blue wavelength range, thereby splitting them in two directions.

The luminous fluxes 291 (292) reflected by the dichroic mirror 281 (282) are gathered by a focusing lens 301 (302) and received by a photoelectric conversion device 321 (322) such as a photodiode via a blue filter 311 (312). The luminous fluxes having transmitted through the dichroic mirror 281 (282) are gathered by a focusing lens 341 (342) and received by a photoelectric conversion device 361 (362) such as a photodiode via a green filter 351 (352).

The optical fiber 251 constructs a first light guiding means, and the optical fiber 252 constructs a second light guiding means. Further, the photoelectric conversion device 321 constructs a first photoelectric conversion means; the photoelectric conversion device 361 constructs a second photoelectric conversion means; the photoelectric conversion device 322 constructs a third photoelectric conversion means; and the photoelectric conversion device 362 constructs a fourth photoelectric conversion means. Furthermore, the dichroic mirror 281 constructs a first splitting means, and the dichroic mirror 282 constructs a second splitting means.

The optical fibers 23, 251, 252 are each formed by a bundle of a multitude of fine fibers made of glass or synthetic resin.

By the optical system 20 constructed as above, the luminous fluxes in the blue wavelength range (first wavelength range) are incident on the photoelectric conversion devices 321, 322, and those in a green wavelength range (second wavelength range) are incident on the photoelectric conversion devices 361, 362. If light reception amounts of the photoelectric conversion devices 321, 322 are I.sub.1 (.lambda.b), I.sub.2 (.lambda.b), and those of the photoelectric conversion device 361, 362 are I.sub.1 (.lambda.kg), I.sub.2 (.lambda.g), the following relationships are established:

I.sub.1 (.lambda.b)<I.sub.1 (.lambda.g),

I.sub.2 (.lambda.b)<I.sub.2 (.lambda.g)

since bilirubin pigmented in the subcutaneous fat has a larger absorption coefficient (absorption factor) for luminous fluxes in the blue wavelength range.

FIG. 3 is a block diagram showing an electric construction of the bilirubin concentration measuring apparatus 10 shown in FIG. 1A. This measuring apparatus 10 is provided with a controller 40 comprised of a CPU, etc., a light source driving device 41 for driving the xenon tube 21, a measurement switch 42 which is automatically turned on when the projection 13 (see FIG. 1) is pushed into the casing 11 against the biasing force of the biasing means as described above, analog-to-digital (A/D) converters 431, 432, 441, 442, a reset switch 45 for clearing the measurement result and bringing the apparatus into a state ready for a next measurement, a ROM 46 for storing a control program for the controller 40 and fixed data set in advance, and a RAM 47 for temporarily storing electric signal data. The RAM 47 has a backup power supply (not shown) lest the content in the memory should be erased. Instead of the RAM 47 having the backup power supply, a reloadable nonvolatile memory such as an EEPROM may be used as a storage means.

The controller 40 has a function as a light emission control means and is electrically connected with the light source driving device 41. AS the projection 13 is pushed to a specified position in the casing 11 against the biasing force of the biasing means as described above, the measurement switch 42 is automatically turned on and an emission command signal is accordingly sent from the controller 40 to the light source driving device 41, which in turn drives the xenon tube 21.

The photoelectric conversion devices 321, 361 for receiving the luminous fluxes 291, 331 having transmitted through the optical fiber 251 (see FIG. 2) and having been split by the dichroic mirror 281 are electrically connected with the controller 40 via the A/D converters 431, 441, respectively. Electric signals S.sub.1 (.lambda.b), S.sub.1 (.lambda.g) proportional to the light reception amounts I.sub.1 (.lambda.b), I.sub.1 (.lambda.g) are outputted from the photoelectric conversion devices 321, 361 to the controller 40.

Likewise, the photoelectric conversion devices 322, 362 for receiving the luminous fluxes 292, 332 having transmitted through the optical fiber 252 (see FIG. 2) and having been split by the dichroic mirror 282 are electrically connected with the controller 40 via the A/D converters 432, 442, respectively. Electric signals S.sub.2 (.lambda.b), S.sub.2 (.lambda.g) proportional to the light reception amounts I.sub.2 (.lambda.b), I.sub.2 (.lambda.g) are outputted from the photoelectric conversion devices 322, 362 to the controller 40.

The controller 40 also has a function as a concentration calculating means; calculates a bilirubin concentration in accordan